Allarity Therapeutics Inc... (ALLR)
0.88
0.08 (10.18%)
At close: Mar 03, 2025, 3:59 PM
1.01
15.22%
Pre-market: Mar 04, 2025, 04:13 AM EST
No 1D chart data available
| Bid | 1 |
| Market Cap | 3.89M |
| Revenue (ttm) | 330.38K |
| Net Income (ttm) | -57.07M |
| EPS (ttm) | -3501.57 |
| PE Ratio (ttm) | n/a |
| Forward PE | -0.03 |
| Analyst | n/a |
| Ask | 1.01 |
| Volume | 9,769,586 |
| Avg. Volume (20D) | 2,015,684 |
| Open | 0.81 |
| Previous Close | 0.80 |
| Day's Range | 0.82 - 0.97 |
| 52-Week Range | 0.68 - 257.40 |
| Beta | 0.25 |
About ALLR
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA, a microt...
Industry Biotechnology
Sector Healthcare
IPO Date Dec 21, 2021
Employees 5
Stock Exchange NASDAQ
Ticker Symbol ALLR
Website https://www.allarity.com
1 day ago
+10.19%
Allarity Therapeutics shares are trading higher af...
Unlock content with
Pro Subscription
6 days ago
+10.17%
Allarity Therapeutics shares are trading higher after the company announced that the securities class action lawsuit against it has been dismissed.
